Title: Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.
Journal: Antimicrobial agents and chemotherapy 20100301
1246819-17-9
55981-09-4
130234-70-7
315240-56-3
150175-94-3
303991-72-2
348165-62-8 | (2R,4S)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate | AA00CKTM | MFCD20278359
33368-94-4 | 4-Imidazolidinone,5-methyl-2-thioxo-(9CI) | AA00CL3D | MFCD00463395
40788-05-4 | 3-(1,1-difluoroethyl)aniline | AA00CLBZ | MFCD20483887
352525-99-6 | 5-Ethoxycarbonylthiophen-2-boronic acid | AA00CLLF | MFCD09952062
329219-36-5 | 3-Chloro-6-fluoro-1-benzothiophene-2-carbohydrazide | AA00CLQI | MFCD00449850
404010-98-6 | 4-Morpholino-2-nitrobenzoic acid | AA00CLX3 | MFCD12198419
42403-77-0 | 4-(Allyloxy)benzophenone | AA00CM4X | MFCD07435384
40056-53-9 | 2-Methyl-1h-imidazole-4,5-dicarbonitrile | AA00CMID | MFCD05975058
325153-01-3 | b-AMino-2-(trifluoroMethyl)benzeneethanol | AA00CMU3 | MFCD11106295
340759-27-5 | 1-[4-(Trifluoromethoxy)benzyl]piperazine | AA00CN5Y | MFCD07368745
